Fulvenat
Brand Name: Fulvenat
Generic Name: Fulvestrant Injection
Composition: Each single-dose vial delivers 250 mg of Fulvestrant in a 5mL sterile solution (50 mg/mL). Excipients include Benzyl Alcohol, Benzyl Benzoate, and Castor Oil.
Administration: For Intramuscular use only.Manufacturer: NATCO PHARMA.
Product Description
Medical Info
Fulvenat® is a specialized oncology medication containing Fulvestrant (250 mg/vial), manufactured by NATCO Pharma. Functioning as a pure estrogen receptor antagonist (SERD), it works by binding irreversibly to estrogen receptors to accelerate their degradation and downregulate tumor growth signals. It is primarily indicated for treating hormone receptor-positive metastatic breast cancer in postmenopausal women experiencing disease progression after anti-estrogen therapy. Administered as a targeted intramuscular injection, Fulvenat® helps overcome traditional hormone therapy resistance mechanisms, offering a critical and degradation-focused therapeutic solution to achieve sustained anti-tumor activity.
Storage & Safety
Precautions & Warnings
Reconstitute only with the prescribed quantity of clean drinking water. Shake well before each use. Complete the full course as prescribed. Discard any unused suspension after 7 days of reconstitution.
Storage
Store in a cool, dry place below 25°C. Protect from light and moisture. Refrigeration after reconstitution is preferred.
Status
Keep all medicines out of reach of children.
